“Glucose, Urea, and Creatinine Laboratory Tests in People Starting Antiretroviral Therapy With Dolutegravir or Efavirenz: A Cohort Study in Belo Horizonte, Brazil”. Research, Society and Development 11, no. 5 (April 12, 2022): e43711528541. Accessed December 15, 2025. https://www.rsdjournal.org/rsd/article/view/28541.